BCAN's Patient Handbook - Bladder Cancer Basics for the Newly Diagnosed



Donate Now to Support the Bladder Cancer Advocacy Network



Join The Online Bladder Cancer Support Community



The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012.
  • We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN.
  • No federal or Marine Corps endorsement is implied.
  • If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.
  • Gonzalgo

    Mark L. Gonzalgo, M.D., Ph.D.
    Associate Professor of Urology
    Stanford University School of Medicine

    Mark L. Gonzalgo, M.D., PhD is currently Associate Professor of Urology and Director of Robotic-Assisted Urologic Cancer Surgery at Stanford University. Dr. Gonzalgo is a board-certified and fellowship-trained urologic oncologist with expertise in robotic prostatectomy, robotic cystectomy for bladder cancer, robotic kidney surgery, and laparoscopic retroperitoneal lymph node dissection for testicular cancer.

    Prior to joining the faculty at Stanford, Dr. Gonzalgo was at The Johns Hopkins Brady Urological Institute where he was Associate Professor of Urology and Director of the Fellowship Program in Urologic Oncology. He received his undergraduate degree with honors from the University of California at Berkeley and completed medical and graduate school at the University of Southern California. Dr. Gonzalgo completed his general surgery and urology training at Johns Hopkins and a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center.

    Dr. Gonzalgo is also a recognized expert in DNA methylation and is particularly interested in developing new diagnostic and therapeutic approaches for cancer detection and treatment. He has carried out pioneering research on the molecular biology and early detection of prostate, bladder, and kidney cancer and has published extensively on the scientific and clinical aspects of these diseases.
    Click here for more information.